Both Moderna MRNA and BioNTech BNTX are leading biotechs at the forefront of messenger RNA (mRNA) technology. The companies rose to prominence with their respective COVID-19 vaccines, but their ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Vertex raised its full-year outlook in Q2 with a growing pipeline across multiple disease areas. Moderna’s mRNA flu vaccine ...
Flu season has started early this year. The number of cases has been rising is the past few weeks at a faster clip than in ...
Opinion
Daniel Griffin: A Gutted CDC and 4,020 Measles Cases Mean Outbreaks Will Outrun Us for a Decade
A 28-year-old lab technician died in Siberia after an accident with a plague sample, and Russia told the WHO there are no cases. In the United ...
Leeds Rhinos legend Ryan Hall announces his retirement at the age of 38.
Some ethics experts have argued that the Trump administration is violating federal laws banning the use of taxpayer dollars for propaganda.
As the fall approaches, it’s time to think about respiratory virus season and how to protect yourself. COVID-19 cases are already rising in most parts of the country as a late summer wave sweeps ...
LIBERTY met all primary/secondary endpoints, with lower 6-day TEAEs/ISRs/hypersensitivity (56.5% vs 91.4%) and systemic AEs (44.1% vs 68.1%) for VYD2311 than vaccine. Over 56 days, ...
5don MSN
Meet the New Nasdaq-100 Stock That’s Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy?
This stock has soared more than 600% this year.
・MRNA’s significant rally began in mid-August, when the company announced late-stage trial results for its cancer vaccine. ・“Moderna has never been a COVID-19 vaccine company,” the CEO said at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results